ALIOF Stock UPDATES Actelion Ltd (ALIOF) 115.3550 08/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Actelion Ltd (ALIOF) 115.3550 $ALIOF

Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 3:22PM CDT
Dynavax Technologies Corporation (DVAX) reported a loss of 9 cents per share in the second quarter of 2014, flat with the year-ago quarter but wider than the Zacks Consensus Estimate of a loss of 6 cents.

Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 8:10AM CDT
Theravance (THRX) incurred a loss of 18 cents in the quarter.

Kindred Healthcare (KND) in Focus: Stock Tumbles 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 7:31AM CDT
Kindred Healthcare has been witnessing flat earnings estimate revision, with its share price falling substantially for last few weeks

The Medicines Company's Orbactiv Approved on Solid SOLO Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 5:10PM CDT
Great news came in The Medicines Company's (MDCO) way when the FDA approved the company's antibiotic Orbactiv.

InterMune Q2 Loss Wider than Expected, Expense Guidance Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 1:50PM CDT
InterMune Inc.'s (ITMN) second-quarter 2014 loss of 67 cents was narrower than the year-ago loss of 78 cents.

Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 11:00AM CDT
Following the earnings release, Integra LifeSciences' (IART) share price rose 1% to eventually close at $48.60 yesterday.

Ligand Gains on Q2 Earnings Beat, Increases Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 10:32AM CDT
Ligand Pharmaceuticals reported better-than-expected second quarter 2014 results and raised its guidance.

Discovery Laboratories Inc. (DSCO) in Focus: Stock Up 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 7:44AM CDT
Discovery Laboratories Inc. (DSCO) was a big mover last session, as the company saw its shares rise nearly 6% on the day.

Sunesis Pharmaceuticals, Inc. (SNSS) Jumps: Stock Rises 9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 8:32AM CDT
Sunesis Pharmaceuticals, Inc. (SNSS) was a big mover last session, as the company saw its shares rise more than 9% on the day.

Tekmira Pharma in Focus as the World Awaits Ebola Treatment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 5:34PM CDT
Tekmira (TKMR) is in focus following Ebola outbreak.

Amgen's Multiple Myeloma Drug Kyprolis Succeeds - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 05, 5:21PM CDT
Amgen (AMGN) intends to submit regulatory applications based on this study in the first half of 2015.

Vertex Pharmaceuticals' Kalydeco Label Expanded in EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 5:05PM CDT
Vertex Pharmaceuticals Inc.'s (VRTX) cystic fibrosis (CF) drug Kalydeco received approval in the EU for eight additional gating mutations.

AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 4:50PM CDT
AbbVie's (ABBV) oncology candidate ABT-414 received orphan drug status in the U.S. and the EU for glioblastoma multiforme.

Regeneron Misses on Earnings in Q2, Eylea Drives Sales Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 2:02PM CDT
Regeneron (REGN) recorded higher than expected revenues due to strong Eylea sales.

Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 2:00PM CDT
Zoetis (ZTS) missed the Zacks Consensus Estimate by a penny.

Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 05, 1:00PM CDT
Actavis (ACT) second quarter results were boosted by the inclusion of products from the Warner Chilcott acquisition.

Ligand Pharmaceuticals (LGND) Jumps: Stock Up 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 8:25AM CDT
Ligand Pharmaceuticals (LGND) was a big mover last session, with shares rising over 10% on the day.

ANI Pharmaceuticals (ANIP) in Focus: Stock Surges 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 7:44AM CDT
ANI Pharmaceuticals, Inc. (ANIP) was a big mover last session, as the company saw its shares surge 11% on the day.

Seattle Genetics Up on Narrower-than-Expected Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 3:20PM CDT
Seattle Genetics reported second-quarter loss per share of 14 cents, narrower than the Zacks Consensus Estimate of a loss of 22 cents.

Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 2:40PM CDT
Alkermes (ALKS) incurred loss in the quarter due to higher expenses.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

California Budget Warning Puts Reserves Back in Focus

Updated Category News Views 118

California’s rainy-day umbrella is getting another hard look, and it should. State Controller Malia M. Cohen is pointing to the Legislative Analyst’s Office fiscal outlook as a reminder that budget discipline and stronger reserves are not ornamental good-government phrases. They are the difference between absorbing a revenue wobble and reaching for ugly fixes after...

Continue Reading
Health In Tech Brings a Tech Veteran Onto Its Board

Updated Category News Views 115

Board appointments rarely make the cash register ring, but they can tell you where management thinks the next bruises are coming from. Health In Tech has added Tim Cortes as an independent director, put him in charge of the Compensation Committee, and placed him on both the Audit and Nominating and Corporate Governance Committees. For an AI-enabled insurance technology...

Continue Reading
Mar-Jac's Safety Milestone Carries Real Operational Weight

Updated Category News Views 84

Four million worked hours without a lost-time accident is the sort of number that ought to make people pause, especially in poultry processing. Mar-Jac Poultry’s Gainesville facility earned Workplace Safety recognition from the Greater Hall Chamber of Commerce after reaching that mark, and this is one corporate achievement that deserves a little less eye-rolling than...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 76

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
Linkind's Best Buy Push Tests Smart Outdoor Demand

Updated Category News Views 199

Holiday lights have quietly become a year-round hardware category, and Linkind wants a louder seat at the table. The smart-lighting brand says three outdoor products have been in Best Buy stores across the United States since October 17, 2026: permanent exterior lights, decorative string lights, and solar pathway lights. That is a real distribution step, not some grand...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 205

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 92

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 121

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Zoomlion’s Australian Service Push Looks Built to Last

Updated Category News Views 0

Five Australian business centres are one thing; getting a stalled crane or earthmover moving again is the whole ballgame. Zoomlion’s Nov. 4 customer gathering in Sydney matters because Chairman and CEO Zhan Chunxin kept the discussion on the unglamorous stuff: product quality, technical support, parts availability and local training. That is exactly where an equipment...

Continue Reading
Leqembi’s Real-World Data Gives BioArctic More Weight

Updated Category News Views 153

A Harder Look at Treatment Staying Power Alzheimer’s drug data rarely arrive without a thicket of caveats, and that is exactly why this Leqembi update deserves a calm read rather than a victory lap. BioArctic’s partner Eisai presented a three-year real-world analysis at CTAD 2026 covering 560 early Alzheimer’s patients across 13 U.S. sites. The headline is striking:...

Continue Reading

Top 5 Most Recently Viewed Articles

Luvme Hair Unveils Exciting Spring-Summer Wig Promotions

Updated Category News Views 366

Transform Your Look with Luvme Hair's Spring-Summer Sale Spring is in the air, and there’s no better time for a fresh start than now. Luvme Hair invites you to rejuvenate your style with their incredible Spring-Summer sale. This special event offers you the chance to save up to $90 on fashionable wigs that are sure to revolutionize your look. Exclusive Discounts Await...

Continue Reading
Transformative Growth and Strong Financials at TC Energy

Updated Category News Views 221

TC Energy Reports Robust Q4 2024 Performance TC Energy Corporation, a leading energy provider, has announced its impressive fourth quarter results, showcasing strong operational and financial metrics. The company is recognized for its strategic priorities that emphasize safety and efficiency, leading to continued growth. Notably, equivalent EBITDA has seen significant...

Continue Reading
Legacy Adoption Services Encourages Families to Adopt Children

Updated Category News Views 176

Legacy Adoption Services Encourages Families to Adopt Children Legacy Adoption Services (LAS) is dedicated to finding loving homes for children in the foster care system. As the largest private adoption provider in the area, LAS has made significant strides in placing children who cannot be raised by their birth parents with suitable adoptive families. Currently, the...

Continue Reading
National Showrooms Expands into Virginia with Key Buy

Updated Category News Views 129

A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...

Continue Reading
Global Uranium Corp. Seeks C$1 Million in New Funding

Updated Category News Views 189

Global Uranium Corp. Plans Private Placement to Raise Funds Global Uranium Corp. (CSE: GURN | FRA: Q3J) has announced an exciting opportunity for investors, initiating a private placement aimed at generating up to C$1,000,000. This strategic move aims to bolster the company's exploration capabilities and facilitate ongoing projects in uranium assets. Details of the...

Continue Reading